Results 131 to 140 of about 72,749 (293)

Everolimus-eluting stents: update on current clinical studies

open access: yesMedical Devices: Evidence and Research, 2011
Dominic J Allocco, Anita A Joshi, Keith D DawkinsBoston Scientific Corporation, Natick, MA, USAAbstract: Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide.
Allocco DJ, Joshi AA, Dawkins KD
doaj  

Patient-specific coronary angioplasty simulations -- a mixed-dimensional finite element modeling approach [PDF]

open access: yesarXiv
Coronary angioplasty with stent implantation is the most frequently used interventional treatment for coronary artery disease. However, reocclusion within the stent, referred to as in-stent restenosis, occurs in up to 10% of lesions. It is widely accepted that mechanical loads on the vessel wall strongly affect adaptive and maladaptive mechanisms. Yet,
arxiv  

Prognostic Impact of Implementation of Heart Team Approach on Cardiovascular Outcomes in Patients With Complex Coronary Artery Disease

open access: yesClinical Cardiology, Volume 48, Issue 5, May 2025.
Implementation of the quality improvement program significantly enhanced HTA activation, led to a significant increase in the selection of CABG as a treatment option. In addition, HTA activation reduced primary composite endpoint after adjustment for confounders.
Po‐Hsueh Su   +5 more
wiley   +1 more source

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

open access: yesAllergy & Rhinology, 2013
Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and ...
Phayvanh P. Sjogren Ph.D.   +2 more
doaj   +1 more source

Preclinical Evaluation of Drug-Eluting Stents for Peripheral Applications [PDF]

open access: bronze, 2004
Robert S. Schwartz   +13 more
openalex   +1 more source

Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans

open access: yesClinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1313-1324, May 2025.
Clopidogrel, an anti‐platelet drug, is used to prevent thrombosis after percutaneous coronary intervention. Clopidogrel resistance results in recurring ischemic events, with African Americans (AA) suffering disproportionately. The aim of this study was to discover novel biomarkers of clopidogrel resistance in African Americans using genome and ...
Guang Yang   +16 more
wiley   +1 more source

Pre‐Percutaneous Coronary Intervention C‐Reactive Protein Levels and In‐Stent Restenosis: A Systematic Review and Meta‐Analysis

open access: yesHealth Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Introduction C‐reactive protein (CRP) is an inflammatory biomarker, implicated in the pathogenesis of atherosclerotic lesion formation, plaque rupture, and coronary thrombosis. The relationship between preprocedural CRP levels and subsequent development of in‐stent restenosis (ISR) after percutaneous coronary intervention (PCI) however remains
Himanshu Rai   +6 more
wiley   +1 more source

Results of endovascular treatment of multivessel coronary artery disease in patients with the different stent types

open access: yesRUDN Journal of Medicine, 2012
Long-term results of endovascular treatment of multivessel coronary artery disease by using different revascularization strategies were analyzed in 171 patients. Duration of follow up ranged from 12 to 18 months.
Ye R Khairutdinov   +5 more
doaj  

Home - About - Disclaimer - Privacy